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A retrospective investigation of skin and soft tissue
infections caused by community-associated methicillin-
resistant  Staphylococcus aureus (MRSA) strains among
inmates in a Wisconsin correctional facility suggested a shift
in MRSA genotype. Case timeline indicated a displacement
of USA400 clone by USA300 clone. The USA300 index
case was associated with an infected new tattoo.
C
ommunity-associated methicillin-resistant Staphylo-
coccus aureus (CA-MRSA) is phenotypically and
genotypically different from healthcare-associated MRSA
(HA-MRSA). Also, risk factors for acquiring CA-MRSA
infections differ from those for acquiring HA-MRSA and
include crowding, close contact, lack of cleanliness, com-
promised skin, and contaminated fomites. These risk fac-
tors have enabled CA-MRSA to infect persons who meet
>1 of these criteria. 
In the 1990s, outbreaks of CA-MRSA–related infec-
tions occurred primarily in certain groups, such as Native
Americans, before disseminating into the general popula-
tion (1–5). More recently, CA-MRSA outbreaks were seen
in unsuspected groups such as military personnel (6,7), ath-
letes (8,9), and inmates at large correctional facilities
(10,11). Molecular typing of strains from these recent out-
breaks showed that most differed from the predominant
clone of the 1990s and belonged to a new CA-MRSAclone,
USA300 (9). In this retrospective study, we report an out-
break of CA-MRSA–associated skin and soft tissue infec-
tions (SSTIs) among inmates of a medium-size correctional
facility in Wisconsin. This outbreak was caused by
USA400 strains but appeared to be displaced by USA300
clonal group after it was introduced into the facility.
The Study
This study was approved by the Institutional Review
Board of Marshfield Clinic and Marshfield Clinic
Research Foundation. Fifteen MRSA isolates were recov-
ered from 15 patients in a correctional facility over a 13-
month period (Figure 1). These isolates were recovered
from SSTI wound samples submitted to Marshfield
Laboratories. The patients were housed in 7 of 10 units
with a common recreation yard at a 1,200-inmate facility
in Wisconsin from May 2002 to May 2003. Infections with
MRSA were rare in this facility; the last reported case of
MRSA was 16 months ago. Because of increased number
of SSTIs during this period, the Wisconsin Division of
Public Health initiated an investigation to determine
whether these strains were epidemiologically related.
All strains were typed by pulsed-field gel electrophore-
sis (PFGE) and staphylococcal cassette chromosome mec
(SCCmec) and tested for virulence genes. Only the first
isolate of each PFGE-based clonal group and 1 additional
isolate from the same clone were analyzed with spa and
multilocus sequence typing.
All 15 patients were men (average age 39 years) and
had SSTIs at various body sites (Figure 2). All patients,
except for inmate Y08, who entered the facility in the sev-
enth month of the outbreak (Figure 1), were incarcerated
for 3 to 56 months before the outbreak. Dates of incarcer-
ation for 2 inmates could not be determined. All 15 isolates
were resistant to β-lactams but sensitive to ciprofloxacin,
gentamicin, rifampicin, tetracycline, trimethoprim-sul-
famethoxazole, and vancomycin.
PFGE analysis grouped these isolates into 2 clonal
groups, USA400 (n = 7, 47%) and USA300 (n = 8, 53%)
(Figure 2). The first isolate and a randomly selected second
isolate of USA300 and USA400 clonal groups were deter-
mined to be sequence type (ST) 8 and ST1, respectively.
The representative USA300 strains were spa type t008
(YHGFMBQBLO), and USA400 strains were spa type
t128 (UJJFKBPE). All 15 strains in both clonal groups
were type IVa SCCmec and positive for virulence factor
Panton-Valentine leukocidin (PVL) genes (lukSF-PV) and
staphylococcal enterotoxin gene sek. Isolates of USA400
were also positive for sea, sec, seh, sel, and fnbA. USA300
strains were positive for fnbA and fnbB.
Both PFGE profiles (Figure 2) of isolates of USA400
clone were previously observed in Native American com-
munities in Wisconsin throughout the 1990s (4). However,
ethnicity of the patients in the current study was not deter-
mined. PFGE profiles of USA300 strains were indistin-
guishable from USA300–0114 type strain (9). Like
USA400 strains, USA300 strains were sensitive to many
classes of antimicrobial drugs. However, unlike type 0014
strain, USA300 strains in this study were sensitive to tetra-
cycline. All 8 strains in the USA300 clonal group were
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resistance by the D-test (data not shown), whereas only 3
(43%) USA400 isolates were resistant to erythromycin and
showed inducible clindamycin resistance. 
After the outbreak investigation, the facility instituted
specific infection control measures for inmates and staff
members. Measures included promoting frequent hand
washing and improving sanitation of laundry, linens,
showers, bathrooms, and equipment in the recreation yard.
Inmates were educated about personal hygiene and conse-
quences of sharing needles and other sharp objects.
Subsequently, the number of MRSA cases in this facility
decreased substantially from 1.25 cases per month during the
study period to 0.67 cases per month over the next 6 months.
Conclusions
Molecular typing data for most reported CA-MRSA
outbreaks in athletes and prisoners since 2000 showed that
these strains belonged to the USA300 clonal group (9).
This clone has also been reported in the general communi-
ty in Michigan, predominantly among young African
Americans with SSTIs (12). Recent reports also indicate
that infections with USA300 strains are emerging in
neonatal and pediatric groups (13,14). Therefore, this new
CA-MRSAclone is not restricted to groups initially report-
ed (6–11) but has reached the community at large (12–14).
When and how USA300 clone became established in this
Wisconsin correctional facility were not clear. Since inter-
state transfer of inmates between correctional facilities is
common, we speculate that the USA300 clone might have
been introduced from such a transfer. The suspected carrier
of USA300 clone in this facility could be a colonized inmate
(Y08), who was incarcerated in the same month in which the
first USA300 strain was identified. The initial case (O15) of
the USA300 clone was in an inmate with an infection of a
new abdominal tattoo acquired in this facility. The trans-
ferred inmate (Y08) was eventually identified as infected
with an identical strain in the eleventh month of the out-
break. We speculate that USA300 probably spread among
the inmates who were in close contact and shared fomites
extensively. Sharing needles and tattoo paraphernalia is
common in many correctional facilities. Irrespective of the
mechanism of introduction, subsequent SSTIs reported from
this facility were mainly due to the newly introduced clone.
USA300 appears to have become the new dominant
CA-MRSA clone in a Wisconsin correctional facility, sim-
ilar to what has occurred in other facilities in the United
States. This clonal displacement could be due to better
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Figure 1. Timeline of incarceration and isolation of
methicillin-resistant Staphylococcus aureus isolates
from different patients. Top panel: baseline shows
months in which a particular isolate was recovered
and patient was identified as infected; y-axis shows
number of patients in each clonal group per month
during the outbreak period. Bottom panel: horizontal
line shows duration in which patients were incarcer-
ated in relation to outbreak period. Month 0 and
month numbers with – and + symbols represent the
respective months of incarceration before and after
onset of the outbreak, respectively. Codes below
months represent patients.
Figure 2. Pulsed-field gel electrophoresis (PFGE)-based
dendrogram of methicillin-resistant Staphylococcus
aureus strains isolated during the outbreak. A genetic
similarity index scale is shown above the dendrogram.
Strain numbers, clone identification, site of infection, and
demographic information are included along each PFGE
lane. MLST, multilocus sequence typing; SCCmec,
staphylococcal cassette chromosome mec; NA, not
available; ND, not determined.fitness of the USA300 clone than the USA400 clone in
vulnerable groups who frequently have >1 risk factor.
However, fitness factors that impart advantage to USA300
strains are not clearly identified. Tenover et al. compared
genomes of several USA300 strains with USA400 and
USA500 and USA100 strains (the last 2 are of healthcare-
associated lineages) (15). They reported that USA300
strains have several unique sequences in pathogenicity
islands such as phi PVL, phi N315, and SaPIn2, in addition
to genes encoding several fibronectin-binding proteins
such as fnbA, fnbB, and ebh. 
Our limited virulence data for USA300 strains in this
study showed that they were positive for fnaA and fnaB,
but lacked enterotoxin genes sea, sec, she, and sel, some of
which are frequently present in the USA400 strains.
Genome sequence data from multidrug-resistant USA300
strain FPR3757 showed that it has a novel mobile genetic
element that contains genes for enzymes of the arginine
deiminase pathway and an oligopeptide permease system
(16). It is speculated that the arginine catabolic mobile ele-
ment, which is common in S. epidermidis but not in S.
aureus, probably offers a selective advantage and con-
tributes toward enhanced growth and survival of USA300
on human skin (16).
Although risk factors such as close contact, crowded
environment, contaminated fomites, lack of cleanliness, and
most importantly, compromised skin barriers are crucial in
transmitting CA-MRSA–related infections, the role of
unknown genomic fitness or virulence factors of USA300
strains cannot be underestimated in its recent spread.
Whether certain conditions besides those mentioned also
favor establishment of one clone of CA-MRSA over anoth-
er in the community settings is also not clear (17).
We document gradual clonal displacement of USA400
by USA300 in a Wisconsin correctional facility. Sharing of
tattoo paraphernalia may be associated with the outbreak
and could be considered a possible risk factor for spread of
CA-MRSA.
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